NOVARTIS INC 13D and 13G filings for Poseida Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-05-08 4:01 pm Sale |
2024-03-31 | 13G | Poseida Therapeutics, Inc. PSTX |
NOVARTIS INC | 0 0.000% |
-5,908,089 (Position Closed) |
Filing |
| 2021-02-12 4:24 pm Purchase |
2020-12-31 | 13G | Poseida Therapeutics, Inc. PSTX |
NOVARTIS INC | 5,908,089 9.600% |
5,908,089 (New Position) |
Filing |